Skip to content

To Study the effect of Guduchyadi Anjan in people with complaints of Praklinna Vartma (Blepharitis).

RANDOMIZED CONTROL CLINICAL TRIAL TO ASSESS THE EFFICACY OF GUDUCHYADI ANJAN IN THE MANAGEMENT OF PRAKLINNA VARTMA WITH SPECIAL REFERENCE TO BLEPHARITIS. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106825
Enrollment
60
Registered
2026-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H028- Other specified disorders of eyelid

Interventions

None listed

Sponsors

Dr Bhagwan Ambadas Mal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients having signs and symptoms of Praklinna Vartma as white scales along the eyelashes, Pakshmakandu(Itching), Pakshma Vartma sandhi shotha(EyeLid Swelling), Pakshma Nistod(Pain),Netrastrava (Discharge). 2)Selection will be irrespective of sex, religion and socio economical class. 3) Paitents of either sex within age group of 18-50yrs.4) Paitents who will give voluntary consent for the study.

Exclusion criteria

Exclusion criteria: 1)Patient having any other known occular pathology. 2)Any past or present history of occular trauma. 3)Patient with k/c/o NLD Block, Dacrocystitis, DM, HBsAG, HIV. 4)Patient having any contagious disease i.e Conjunctivitis etc. 5)Patient recently undergoes eye surgeries. 6)One eyed patient.

Design outcomes

Primary

MeasureTime frame
To Evaluate The Efficacy of Guduchyadi Anjan in Praklinna Vartma W.S.R to Blepharitis.Timepoint: 15 days

Secondary

MeasureTime frame
1)To Study the Classical literature Praklinna Vartma. 2)To Study Literature related to Blepharitis. 3)To Study Anjan Vidhi in Detail.Timepoint: 15 Days

Countries

India

Contacts

Public ContactDr Bhagwan Ambadas Mal

LKR Ayurvedic College and Research Centre

drsutaryuvrajmsophth@gmail.com9850544418

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026